A Phase I/IIa Clinical Trial of Autologous Hematopoietic Stem Cell Transplantation in Amyotrophic Lateral Sclerosis

To verify the safety and potential effect on ALS progression of a low-intensity immunosuppressive regimen followed by autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis patients.